Federal contractor · MORRISTOWN, NJ

CAPSUGEL, INC.

No contract obligations recorded for CAPSUGEL, INC. in FY2026. Since FY2017: $28.5K.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
RARMXSHNJ3Y8
Parent company
LONZA WALKERSVILLE, INC
Other than small business
Open in the contracts explorerRelationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

Part of the ARCH CHEMICALS, INC. company family: 5 registered entities, -$150.4K in FY2026 together. See the family

  1. ARCH CHEMICALS, INC.ALPHARETTA, GA · Family page
    $0
  2. ARCH CHEMICALS, INC.LAKE CHARLES, LA
    $0
  3. LONZA ROCKLAND, INC.ROCKLAND, ME
    $0
  4. LONZA WALKERSVILLE, INCWALKERSVILLE, MD
    -$150.4K

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 6.7KFY2017
  2. 21.8KFY2019

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for CAPSUGEL, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

2 companies · $189.3K reported

  1. MRIGLOBAL$154.6K
    KANSAS CITY, MO · 1 subaward · Management, scientific, and technical consulting services
  2. RESEARCH TRIANGLE INSTITUTE$34.8K
    RESEARCH TRIANGLE PARK, NC · 1 subaward · Scientific research and development services

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 7 markets (agency × industry), FY2024–FY2026.

  1. ON DEMAND PHARMACEUTICALS INC$325K
    ROCKVILLE, MD · 88% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. BIOLEGEND, INC.$373.6K−82% in FY2026
    SAN DIEGO, CA · 93% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturingNational Institutes of Health · Navigational, measuring, electromedical, and control instruments manufacturing
  3. QUVA PHARMA, INC.$376.3K
    SUGAR LAND, TX · 88% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.